NCT00479596 This is a Prospective, Randomized, Double-Blind Study Comparing Intravesical Injection of Botox® to Placebo. Status UNKNOWN Phase PHASE2/PHASE3
NCT00478881 A Study To Assess If 10 mg Vardenafil (BAY38-9456) Taken Twice Daily For 6 Weeks Has An Effect On Bladder Function Status COMPLETED Phase PHASE2
NCT00465894 Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms Status COMPLETED Phase NA
NCT00461292 Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder Status COMPLETED Phase PHASE3
NCT00444925 Clinical Trial to Evaluate the Efficacy and Safety of Fesoterodine in Comparison to Tolterodine for Overactive Bladder (OAB) Status COMPLETED Phase PHASE3
NCT00441428 Safety And Efficacy Of Solifenacin In Men With Overactive Bladder (OAB) And Detrusor Underactivity Status COMPLETED Phase N/A
NCT00439192 ELB245 for 12 Weeks Versus 4mg Tolterodine in Patients With Incontinent Overactive Bladder (OAB) Status TERMINATED Phase PHASE2
NCT00439140 Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Neurogenic Overactive Bladder Status TERMINATED Phase PHASE3
NCT00437528 Safety and Applicability Study of a Novel Heat Flow Sensor Unit for Measuring Urinary Bladder Capacity Status UNKNOWN Phase N/A
NCT00431041 Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR) Status COMPLETED Phase PHASE4
NCT00427596 A Two-Part Study to Determine: Best Medication Formulation and Food Effect Status COMPLETED Phase PHASE1
NCT00425100 A Clinical Trial To Assess Fesoterodine On Treatment Satisfaction And Symptom Improvement In Overactive Bladder Patients Status COMPLETED Phase PHASE3
NCT00350636 A Comparison of a New Drug to Treat Overactive Bladder vs. Placebo Status COMPLETED Phase PHASE3
NCT00343486 Dose Ranging Study Of Solabegron Versus Placebo In Female Patients With Overactive Bladder Symptoms Status COMPLETED Phase PHASE2
NCT00337558 A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) Status COMPLETED Phase PHASE4
NCT00337090 A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON) Status COMPLETED Phase PHASE2
NCT00332319 Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients Status TERMINATED Phase PHASE2
NCT00321477 A Study Of GW679769 Compared To Placebo In Women With Overactive Bladder Status COMPLETED Phase PHASE2